Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years.
Market Analysis and Insights: Global Womens Health Market
The global Womens Health market is projected to grow from US$ 33610 million in 2023 to US$ 44780 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.
Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.
Report Includes
This report presents an overview of global market for Womens Health market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Womens Health, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Womens Health, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Womens Health revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Womens Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Womens Health revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Allergan, Bayer, Merck, Pfizer, Teva Pharmaceutical, Agile Therapeutics, Amgen, Apothecus Pharmaceutical and AstraZeneca, etc.
By Company
Allergan
Bayer
Merck
Pfizer
Teva Pharmaceutical
Agile Therapeutics
Amgen
Apothecus Pharmaceutical
AstraZeneca
Blairex Laboratories
Bristol-Myers Squibb
Ferring
Segment by Type
Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovary Syndrome
Infertility
Menopause
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Womens Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Womens Health companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Womens Health revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Womens Health Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Postmenopausal Osteoporosis
1.2.3 Endometriosis
1.2.4 Polycystic Ovary Syndrome
1.2.5 Infertility
1.2.6 Menopause
1.2.7 Others
1.3 Market by Application
1.3.1 Global Womens Health Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Womens Health Market Perspective (2018-2029)
2.2 Global Womens Health Growth Trends by Region
2.2.1 Womens Health Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Womens Health Historic Market Size by Region (2018-2023)
2.2.3 Womens Health Forecasted Market Size by Region (2024-2029)
2.3 Womens Health Market Dynamics
2.3.1 Womens Health Industry Trends
2.3.2 Womens Health Market Drivers
2.3.3 Womens Health Market Challenges
2.3.4 Womens Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Womens Health by Players
3.1.1 Global Womens Health Revenue by Players (2018-2023)
3.1.2 Global Womens Health Revenue Market Share by Players (2018-2023)
3.2 Global Womens Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Womens Health, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Womens Health Market Concentration Ratio
3.4.1 Global Womens Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Womens Health Revenue in 2022
3.5 Global Key Players of Womens Health Head office and Area Served
3.6 Global Key Players of Womens Health, Product and Application
3.7 Global Key Players of Womens Health, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Womens Health Breakdown Data by Type
4.1 Global Womens Health Historic Market Size by Type (2018-2023)
4.2 Global Womens Health Forecasted Market Size by Type (2024-2029)
5 Womens Health Breakdown Data by Application
5.1 Global Womens Health Historic Market Size by Application (2018-2023)
5.2 Global Womens Health Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Womens Health Market Size (2018-2029)
6.2 North America Womens Health Market Size by Type
6.2.1 North America Womens Health Market Size by Type (2018-2023)
6.2.2 North America Womens Health Market Size by Type (2024-2029)
6.2.3 North America Womens Health Market Share by Type (2018-2029)
6.3 North America Womens Health Market Size by Application
6.3.1 North America Womens Health Market Size by Application (2018-2023)
6.3.2 North America Womens Health Market Size by Application (2024-2029)
6.3.3 North America Womens Health Market Share by Application (2018-2029)
6.4 North America Womens Health Market Size by Country
6.4.1 North America Womens Health Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Womens Health Market Size by Country (2018-2023)
6.4.3 North America Womens Health Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Womens Health Market Size (2018-2029)
7.2 Europe Womens Health Market Size by Type
7.2.1 Europe Womens Health Market Size by Type (2018-2023)
7.2.2 Europe Womens Health Market Size by Type (2024-2029)
7.2.3 Europe Womens Health Market Share by Type (2018-2029)
7.3 Europe Womens Health Market Size by Application
7.3.1 Europe Womens Health Market Size by Application (2018-2023)
7.3.2 Europe Womens Health Market Size by Application (2024-2029)
7.3.3 Europe Womens Health Market Share by Application (2018-2029)
7.4 Europe Womens Health Market Size by Country
7.4.1 Europe Womens Health Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Womens Health Market Size by Country (2018-2023)
7.4.3 Europe Womens Health Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Womens Health Market Size (2018-2029)
8.2 China Womens Health Market Size by Type
8.2.1 China Womens Health Market Size by Type (2018-2023)
8.2.2 China Womens Health Market Size by Type (2024-2029)
8.2.3 China Womens Health Market Share by Type (2018-2029)
8.3 China Womens Health Market Size by Application
8.3.1 China Womens Health Market Size by Application (2018-2023)
8.3.2 China Womens Health Market Size by Application (2024-2029)
8.3.3 China Womens Health Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Womens Health Market Size (2018-2029)
9.2 Asia Womens Health Market Size by Type
9.2.1 Asia Womens Health Market Size by Type (2018-2023)
9.2.2 Asia Womens Health Market Size by Type (2024-2029)
9.2.3 Asia Womens Health Market Share by Type (2018-2029)
9.3 Asia Womens Health Market Size by Application
9.3.1 Asia Womens Health Market Size by Application (2018-2023)
9.3.2 Asia Womens Health Market Size by Application (2024-2029)
9.3.3 Asia Womens Health Market Share by Application (2018-2029)
9.4 Asia Womens Health Market Size by Region
9.4.1 Asia Womens Health Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Womens Health Market Size by Region (2018-2023)
9.4.3 Asia Womens Health Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Womens Health Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Womens Health Market Size by Type
10.2.1 Middle East, Africa, and Latin America Womens Health Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Womens Health Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Womens Health Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Womens Health Market Size by Application
10.3.1 Middle East, Africa, and Latin America Womens Health Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Womens Health Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Womens Health Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Womens Health Market Size by Country
10.4.1 Middle East, Africa, and Latin America Womens Health Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Womens Health Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Womens Health Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Womens Health Introduction
11.1.4 Allergan Revenue in Womens Health Business (2018-2023)
11.1.5 Allergan Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Womens Health Introduction
11.2.4 Bayer Revenue in Womens Health Business (2018-2023)
11.2.5 Bayer Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Womens Health Introduction
11.3.4 Merck Revenue in Womens Health Business (2018-2023)
11.3.5 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Womens Health Introduction
11.4.4 Pfizer Revenue in Womens Health Business (2018-2023)
11.4.5 Pfizer Recent Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical Womens Health Introduction
11.5.4 Teva Pharmaceutical Revenue in Womens Health Business (2018-2023)
11.5.5 Teva Pharmaceutical Recent Developments
11.6 Agile Therapeutics
11.6.1 Agile Therapeutics Company Details
11.6.2 Agile Therapeutics Business Overview
11.6.3 Agile Therapeutics Womens Health Introduction
11.6.4 Agile Therapeutics Revenue in Womens Health Business (2018-2023)
11.6.5 Agile Therapeutics Recent Developments
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Womens Health Introduction
11.7.4 Amgen Revenue in Womens Health Business (2018-2023)
11.7.5 Amgen Recent Developments
11.8 Apothecus Pharmaceutical
11.8.1 Apothecus Pharmaceutical Company Details
11.8.2 Apothecus Pharmaceutical Business Overview
11.8.3 Apothecus Pharmaceutical Womens Health Introduction
11.8.4 Apothecus Pharmaceutical Revenue in Womens Health Business (2018-2023)
11.8.5 Apothecus Pharmaceutical Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Womens Health Introduction
11.9.4 AstraZeneca Revenue in Womens Health Business (2018-2023)
11.9.5 AstraZeneca Recent Developments
11.10 Blairex Laboratories
11.10.1 Blairex Laboratories Company Details
11.10.2 Blairex Laboratories Business Overview
11.10.3 Blairex Laboratories Womens Health Introduction
11.10.4 Blairex Laboratories Revenue in Womens Health Business (2018-2023)
11.10.5 Blairex Laboratories Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Womens Health Introduction
11.11.4 Bristol-Myers Squibb Revenue in Womens Health Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Ferring
11.12.1 Ferring Company Details
11.12.2 Ferring Business Overview
11.12.3 Ferring Womens Health Introduction
11.12.4 Ferring Revenue in Womens Health Business (2018-2023)
11.12.5 Ferring Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Allergan
Bayer
Merck
Pfizer
Teva Pharmaceutical
Agile Therapeutics
Amgen
Apothecus Pharmaceutical
AstraZeneca
Blairex Laboratories
Bristol-Myers Squibb
Ferring
*If Applicable.